"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 17 | 3 | 20 |
| 1996 | 14 | 6 | 20 |
| 1997 | 15 | 9 | 24 |
| 1998 | 14 | 3 | 17 |
| 1999 | 12 | 2 | 14 |
| 2000 | 17 | 5 | 22 |
| 2001 | 21 | 5 | 26 |
| 2002 | 26 | 10 | 36 |
| 2003 | 35 | 11 | 46 |
| 2004 | 47 | 14 | 61 |
| 2005 | 34 | 12 | 46 |
| 2006 | 36 | 11 | 47 |
| 2007 | 52 | 14 | 66 |
| 2008 | 49 | 13 | 62 |
| 2009 | 43 | 11 | 54 |
| 2010 | 49 | 6 | 55 |
| 2011 | 59 | 14 | 73 |
| 2012 | 69 | 9 | 78 |
| 2013 | 64 | 15 | 79 |
| 2014 | 89 | 17 | 106 |
| 2015 | 107 | 9 | 116 |
| 2016 | 79 | 22 | 101 |
| 2017 | 91 | 12 | 103 |
| 2018 | 88 | 9 | 97 |
| 2019 | 107 | 17 | 124 |
| 2020 | 135 | 12 | 147 |
| 2021 | 129 | 7 | 136 |
| 2022 | 120 | 0 | 120 |
| 2023 | 113 | 3 | 116 |
| 2024 | 66 | 28 | 94 |
| 2025 | 23 | 1 | 24 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference. Oncoimmunology. 2025 Dec; 14(1):2507856.
-
Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2025 May 15; 31(10):1831-1840.
-
A randomized controlled trial adding behavioral counseling to supervised physical activity in people living with and beyond cancer (BOOST-UP-): a study protocol for a live remotely-delivered behavior change intervention. BMC Cancer. 2025 May 09; 25(1):847.
-
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. J Immunother Cancer. 2025 May 02; 13(5).
-
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer. Lancet Oncol. 2025 May; 26(5):e253-e263.
-
Designing live bacterial therapeutics for cancer. Adv Drug Deliv Rev. 2025 Jun; 221:115579.
-
Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study. Support Care Cancer. 2025 Apr 08; 33(5):362.
-
Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons. Clin Transl Sci. 2025 Apr; 18(4):e70227.
-
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas. Clin Cancer Res. 2025 Apr 01; 31(7):1233-1242.
-
NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of Chemotherapy: A Phase II Clinical Trial. Cancer Med. 2025 Apr; 14(7):e70549.